Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 Positive
Clinical trial NCT03178071 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT03178071
- Sponsor
- Pfizer
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.